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Abstract
The Zcchc11 enzyme is implicated in microRNA (miRNA) regulation. It can uridylate let-7 precursors to decrease quantities
of the mature miRNA in embryonic stem cell lines, suggested to mediate stem cell maintenance. It can uridylate mature
miR-26 to relieve silencing activity without impacting miRNA content in cancer cell lines, suggested to mediate cytokine and
growth factor expression. Broader roles of Zcchc11 in shaping or remodeling the miRNome or in directing biological or
physiological processes remain entirely speculative. We generated Zcchc11-deficient mice to address these knowledge
gaps. Zcchc11 deficiency had no impact on embryogenesis or fetal development, but it significantly decreased survival and
growth immediately following birth, indicating a role for this enzyme in early postnatal fitness. Deep sequencing of small
RNAs from neonatal livers revealed roles of this enzyme in miRNA sequence diversity. Zcchc11 deficiency diminished the
lengths and terminal uridine frequencies for diverse mature miRNAs, but it had no influence on the quantities of any
miRNAs. The expression of IGF-1, a liver-derived protein essential to early growth and survival, was enhanced by Zcchc11
expression in vitro, and miRNA silencing of IGF-1 was alleviated by uridylation events observed to be Zcchc11-dependent in
the neonatal liver. In neonatal mice, Zcchc11 deficiency significantly decreased IGF-1 mRNA in the liver and IGF-1 protein in
the blood. We conclude that the Zcchc11-mediated terminal uridylation of mature miRNAs is pervasive and physiologically
significant, especially important in the neonatal period for fostering IGF-1 expression and enhancing postnatal growth and
survival. We propose that the miRNA 39 terminus is a regulatory node upon which multiple enzymes converge to direct
silencing activity and tune gene expression.
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Introduction
Non-canonical poly(A) polymerases (PAPs) comprise a family of
enzymes highly conserved across Eukaryota and capable of
catalyzing the template-independent transfer of uridines and
adenines onto single-stranded RNA substrates [1,2]. Several
non-canonical PAPs, including the uridyltransferase Zcchc11
(PAPD3/TUT4), can mediate 39 terminal nucleotide additions
to mature miRNA [3,4,5]. The uridylation or adenylation of
mature miRNAs does not impact miRNA quantity, but instead
limits miRNA silencing of select, targeted transcripts [3,5]. By
other means, Zcchc11 can regulate quantities of mature miRNA.
In mouse embryonic stem cell lines, Zcchc11 recognizes
complexes of Lin28 and pre-let-7 and adds an oligouridine tail
to the 39 terminus of the pre-miRNA, preventing maturation and/
or enhancing degradation of the precursor [6,7]. Knockdown of
Zcchc11 or Lin28 in stem cell lines increases mature let-7 and
decreases pluripotency markers [6,8,9]. Both of these models
propose that uridylation by Zcchc11 circumvents miRNA-
mediated transcript silencing, but they invoke disparate mecha-
nisms. While not mutually exclusive, they have never been
concurrently examined, and each has been demonstrated only in
reductionist cell line systems focusing on small subsets of miRNAs.
The degree to which miRNA quantity and/or sequence diversity
may be remodeled by Zcchc11 (or any non-canonical PAP) and
the roles of Zcchc11 in integrated biological systems remain
speculative and represent major knowledge gaps.
Results
Zcchc11 enhances the growth and survival of young
mice
We derived a line of mutant mice from embryonic stem cells
carrying a gene-trap insertion in the fourth intron of the 31 exon
Zcchc11 gene [10]. This mutation (Figure S1A) was upstream of all
known protein domains and effectively ablated Zcchc11 expres-
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limit let-7 in embryonic stem cell lines [6,7], we anticipated that its
loss might be incompatible with development and viability in utero.
Surprisingly, there was no evidence of decreased fitness through
gestation, with offspring from heterozygous parents born in
Hardy-Weinberg equilibrium (Figure 1B) and displaying normal
morphology and weights (Figure 1C). Furthermore, we observed
no increase in let-7 content in Zcchc11-deficient embryonic stem
cells compared to embryonic stem cells that were wild type or
heterozygous for Zcchc11 (Figure 1D). Thus, Zcchc11-deficient
embryonic stem cells were not disadvantaged, and Zcchc11 is
dispensable for embryonic stem cell maintenance.
By post-partum day 8, we observed approximately 50%
mortality in the Zcchc11-deficient mice (Figure 1B). While initially
similar in size, Zcchc11-deficient pups grew more slowly than wild
type littermates in the first week (Figure 1C). Most organs were
proportionately affected, suggesting systemic effects (Figure 1E).
Early bodyweight differences were sustained for months (Figure
S1C), but otherwise those mutants surviving beyond the perinatal
period displayed no defects in lifespan or gross or histologic
morphology (Figure S1D). In contrast to the more restricted tissue
expression observed in adult mice [3], Zcchc11 expression was
found to be nearly ubiquitous in the first days after birth with
protein levels in all organs examined except the thymus decreasing
over time (Figure 1F). These findings highlight the neonatal period
as a time when Zcchc11 is fundamental to mouse growth and
development.
Zcchc11 does not affect mature miRNA quantities
To address the predominant functions for Zcchc11 in miRNA
biology in vivo, we used deep sequencing of small RNAs to
simultaneously determine mature miRNA quantity and end-
modification in an unbiased and comprehensive fashion. We
focused our deep sequencing efforts on the liver because it has a
relatively homogenous population of cells, Zcchc11 is strongly
expressed in this tissue in young mice, and there was precedent for
miRNA terminal modifications in the liver [4]. Libraries of small
RNAs were constructed from 3 different paired sets of 8-day-old
livers from Zcchc11
+/+ or Zcchc11
2/2 sex- and littermate-matched
mice. More than 85 million sequences were obtained, which
exhibited a total of .75% alignment to miRBase (Table S1).
Since Zcchc11-mediated uridylation of let-7 precursors in
embryonic stem cells diminishes mature let-7 abundance [6,7],
we expected to observe increased quantities of these and perhaps
other miRNAs in the Zcchc11-deficient livers. Instead, all
detectable miRNAs exhibited a strong correlation in quantity
between wild type and Zcchc11-deficient mice (Figure 2A). There
were no significant differences due to genotype in the content of
any mature miRNA in the liver. Cross-method validation using
qRT-PCR analyses of representative miRNAs of interest con-
firmed that levels of let-7a, let-7b, let-7c, miR-122, miR-139, and
miR-379 were equivalent (Figure 2B). A third independent
method, northern blotting, also confirmed no increase in let-7a
due to Zcchc11 deficiency (Figure 2C). Consistent with this
observation, there was no aberrant expression of core miRNA
machinery, including Drosha, Dicer, and Argonaute in Zcchc11-
deficient livers (Figure 2D). Because mature miRNA levels were
unchanged, we considered that Lin28 proteins might be absent
from these tissues. While Lin28a was undetectable, Lin28b was
present in young mouse livers and was unaffected by Zcchc11
deficiency (Figure 2E). This may be relevant, since Lin28a is more
specifically tied to Zcchc11 regulation of let-7, relating to
cytoplasmic localization [11]. Altogether, the present data suggest
that the high level of Zcchc11 expression in the young liver does
not influence mature miRNA abundance, including let-7 family
members.
Zcchc11 mediates mature miRNA lengths and terminal
uridine frequencies
In addition to precursor modification, Zcchc11 family members
are capable of uridylating or adenylating the 39 termini of mature
miRNAs [3,4,5,12]_ENREF_13. While the general pattern of
small RNA read lengths from our deep sequence libraries was
similar between genotypes, with sequence lengths of 21–23
nucleotides predominating, there were significantly fewer 23
nucleotide-long sequences in the livers of the Zcchc11-deficient
mice (Figure 3A). To identify potential enzymatic additions by
Zcchc11, aligned sequences were interrogated at the position 1
nucleotide beyond the 39 terminal residue listed in miRBase
[13,14]. Potential uridylation and adenylation events, included if
present at levels of 1 or more sequence per 1,000 reads, were
identified for many miRNA species in the livers of wild type mice
(Figure S2). Some of these highly modified species, such as miR-
26b and miR-122, match those identified previously [4,5], while
others represent novel modification targets. We compared the
levels of terminal adenines and uridines in mutant mice for each of
the miRNAs that were so modified in the livers of wild type mice.
A waterfall plot depicting the changes in terminal adenines
between the livers of wild type and Zcchc11-deficient mice
revealed a balanced distribution with a mean centered around 0
(Figure 3B–3C). Conversely, the distribution of terminal uridines
was significantly skewed, with most of the sequences bearing
terminal uridines occurring less frequently in the absence of
Zcchc11, suggesting that miRNA uridylation was broadly
decreased in Zcchc11-deficient livers (Figure 3B–3C). The
expression of other non-canonical PAPs, including PAPD5,
GLD-2, and Zcchc6, were unchanged in the livers of Zcchc11
deficient mice (Figure 3D–3E).
Terminal uridines that are 39 of the expected mature miRNA
sequence and dependent on Zcchc11 most likely represent
enzymatic additions, but they could also arise from alternative
Author Summary
MicroRNAs (miRNAs) are molecules that regulate gene
expression, usually serving silencing functions. Mecha-
nisms regulating miRNAs are poorly understood. In test
tube experiments, the enzyme Zcchc11 adds uridines to
the ends of miRNAs and their precursors, with uridyation
of miRNA precursors decreasing the quantities of mature
miRNAs and uridylation of mature miRNAs decreasing their
silencing activity. Whether, when, and to what effect
Zcchc11 alters miRNA in living animals has never previ-
ously been reported. To understand functions of Zcchc11
in integrative biology, we generated mice deficient in
Zcchc11. Mutant mice were born normally, but some died
soon after birth and survivors grew poorly. No miRNA
quantities were changed in tissues sampled from these
mice, but mature miRNAs were less likely to have
additional uridines on their ends. Some miRNAs that were
uridylated by Zcchc11 targeted a critical growth factor
known as insulin-like growth factor 1 (IGF-1), but they did
so less effectively when uridylated. Zcchc11-deficient mice
had decreased amounts of IGF-1 in the liver and blood.
These data reveal that Zcchc11 is an important enzyme in
living animals for uridylating mature miRNAs, enhancing
IGF-1 expression, and promoting neonatal growth and
survival, suggesting a novel mode of gene regulation that
is biologically significant.
Zcchc11 Deficiency In Vivo
PLOS Genetics | www.plosgenetics.org 2 November 2012 | Volume 8 | Issue 11 | e1003105Figure 1. Zcchc11 enhances growth and fitness through the perinatal period. (A) Immunoblots of organs from C57BL/6 and Zcchc11
2/2
mice show deletion of Zcchc11 protein. (B) Fraction of homozygous Zcchc11-deficient offspring from Zcchc11
+/2 parents at day E14, P1, P8 and P21,
indicating decreased survival by day 8. *p,0.05 vs. 0.25 by Chi-squared test, N as indicated. (C) Body weights of Zcchc11
+/+ and Zcchc11
2/2
littermates at day 1 and 8 (*p,0.05), showing poor growth in mutants. (D) Let-7 content in primary embryonic stem cell (ESC) cultures that were wild
type (+/+), heterozygous (+/2), or deficient (2/2) in Zcchc11 expression, showing no significant effects of genotype (by two-way ANOVA). (E)
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we analyzed miRNAs with terminal uridines that were not
genomically encoded and therefore could only result from
enzymatic addition, referred to as unambiguous uridylation
events. For miRNAs observed in every library from both
genotypes, 179 different species showed evidence of unambiguous
uridine additions in all 3 wild type libraries, whereas only 118 did
so across mutant libraries (p,0.001, x
2 test). This analysis
supports the conclusions of the more comprehensive analyses
above (Figure 3), together indicating definitively that Zcchc11
deficiency decreases the terminal uridylation of mature miRNAs.
These results provide the first compelling evidence, to our
knowledge, that Zcchc11 plays a specific and essential role in
the length and uridylation of a broad swath of mature miRNAs in
vivo.
Zcchc11 uridyltransferase activity contributes to IGF-1
expression
Of the miRNAs ending in uridine more frequently in wild type
livers compared to mutants, many were predicted to target IGF-1
(Figure 3B), a growth factor which is liver-derived and essential to
early growth and survival in mammals [15,16]. The IGF-1 39-
UTR is highly polymorphic [17]. We found that an approximately
6.5 kb 39-UTR was predominant in 8 day old mouse livers
(Figure 4A). We cloned this isoform from the livers of C57BL/6
mice and incorporated it into a reporter plasmid to assess the effect
of Zcchc11 on the IGF-1 39-UTR. Addition of this UTR
significantly decreased reporter expression vs. the coding region
alone (Figure 4B), as would be expected for a long 39-UTR that
likely contains many negative regulatory elements. To test the
effect of Zcchc11 expression on the IGF-1 39-UTR, this reporter
was co-transfected into cells along with enhanced GFP (EGFP,
control), wild type Zcchc11, or Zcchc11 mutants lacking
enzymatic activity. Overexpression of wild type Zcchc11 signifi-
cantly increased levels of the IGF-1 39-UTR reporter (Figure 4C),
indicating that Zcchc11 facilitates IGF-1 expression through its 39-
UTR. Importantly, a catalytically null mutant Zcchc11, in which 2
aspartic acid residues necessary for uridyltransferase activity were
changed to alanines [3], was significantly less capable of
amplifying the IGF-1 reporter (Figure 4C). Moreover, an N-
terminal deletion mutant of Zcchc11 lacking the C-terminal half of
the protein and devoid of the uridyltransferase domain, PAP-
associated domains, and RNA-binding zinc knuckles was com-
pletely incapable of altering IGF-1 expression (Figure 4C). Thus,
Zcchc11 can enhance IGF-1 expression through a uridyltransfer-
ase-dependent mechanism.
MicroRNA silencing of IGF-1 is inhibited by terminal
uridine addition
Of the multiple miRNAs which had terminal uridines that
required Zcchc11 in our deep sequencing datasets and were
predicted to target the 39 UTR of IGF-1 (Figure 3B), we examined
the ability of 4 (miR-126-5p, miR-194-2-3p, miR-379 and Let-7d)
to suppress IGF-1 expression. Cells were co-transfected with the
IGF-1 39-UTR luciferase reporter construct along with either
miRNA mimetics or a control non-targeting sequence. MiR-126-
5p, miR-194-2-3p, and miR-379, but not Let-7d, significantly
silenced the IGF-1 reporter (Figure 5A). We next assessed the
influence of terminal uridine additions on the silencing activity of
these miRNAs by comparing the effects on the IGF-1 reporter of
unmodified miRNA mimetics to those with 2 uridines added onto
the 39 end. The uridylation of miR-126-5p or miR-379
significantly diminished IGF-1 silencing by these miRNAs, while
uridylation of miR-194-2-3p had no effect (Figure 5B). These data
demonstrate that uridylation of specific miRNA species may
influence silencing. Interestingly, varying the length of the terminal
uridine tail, to reflect the different forms observed for each of these
miRNAs in our deep sequencing datasets, had minimal impact for
both miR-126-5p and miR-379 (Figure 5C–5D), demonstrating
that even a single uridine is sufficient to mitigate silencing by these
miRNAs. Terminal uridylation did not completely eliminate
silencing effects, suggesting that these end modifications provide
tuning ability rather than a binary on-off switch. The effects of
adding uridine(s) to the 39 terminus were modest in comparison to
the effects of altering bases in the seed region of the 59 terminus,
which completely eliminated repression of the IGF-1 39-UTR
reporter (Figure 5E), indicating that the effects described here
reflect a scaling of canonical miRNA activity. Interestingly, when 2
miRNAs targeting the IGF-1 39-UTR were simultaneously co-
transfected, silencing was minimally influenced if only 1 of the 2
was uridylated, but it was very effectively attenuated when both
were uridylated (Figure 5F). These data indicate that uridylation
events have cumulative effects across the set of miRNAs targeting
a given 39-UTR. The combination of such effects provides a wide
dynamic range over which expression can be tuned.
IGF-1 expression is compromised by Zcchc11 deficiency
in vivo
The above results, demonstrating that Zcchc11 contributes to
the uridylation of miRNAs which target IGF-1 and that miRNA
uridylation relieves silencing to enhance IGF-1 expression,
suggested the possibility that the decreased size and survival of
Zcchc11-deificient mice may be associated with decreased
expression of IGF-1 in vivo. Supporting this hypothesis, Zcchc11
deficiency reduced hepatic IGF-1 expression to approximately half
of wild type levels (Figure 6A). To differentiate regulation of the
IGF-1 transcript in the liver from upstream signals, we examined
STAT5 phosphorylation in the liver and growth hormone (GH) in
the blood. Neither was affected by Zcchc11 deficiency (Figure 6B–
6C), suggesting a local hepatocyte role for this enzyme in
regulating IGF-1 mRNA. To test whether IGF-1 expression was
selectively enhanced or whether many diverse growth factors were
dependent upon Zcchc11 in neonatal mouse livers, we performed
a PCR array for mouse growth factor transcripts. Only IGF-1 was
strongly expressed and diminished by Zcchc11 deficiency in these
livers (Figure 6D). The impact of Zcchc11 deficiency on IGF-1 was
comparable to its impact on IL-6, which was previously
demonstrated to depend on Zcchc11 [3]. These data reveal that
Zcchc11 effects are transcript-specific rather than transcriptome-
wide, and that IGF-1 is a particular target of Zcchc11 regulation.
We also measured the expression of histone H3 in these livers,
since this protein contributes to cell proliferation and is enhanced
by Zcchc11 in some but not other cell lines [18,19]. There was no
effect of Zcchc11 deficiency on histone H3 content in the young
mouse liver (Figure 6E). Reflecting the changes in liver transcript,
Zcchc11 deficiency reduced circulating IGF-1 concentrations to
Proportion of organ weight to body weight in 8-day-old C57BL/6 and Zcchc11
2/2 mice, showing no difference between genotypes across tissues and
suggesting a system-wide growth defect rather than organ-specific effects. (F) Age-dependent expression of Zcchc11, as shown by immunoblots of
tissues from C57BL/6 mice at 2 days, 2 weeks, and 10 weeks of age, reveals strongest expression in most organs at young ages. GAPDH is provided as
a loading control.
doi:10.1371/journal.pgen.1003105.g001
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PLOS Genetics | www.plosgenetics.org 4 November 2012 | Volume 8 | Issue 11 | e1003105Figure 2. Zcchc11 deficiency does not affect quantities of mature miRNAs or miRNA–related proteins in the liver. Three deep
sequencing libraries were created from livers of sex- and littermate-matched 8-day-old Zcchc11
+/+ or Zcchc11
2/2 mice. (A) Mature miRNA content,
expressed as reads per million (RPM) was compared for wild type and Zcchc11-deficient livers (correlation coefficient, r=0.975). (B) Quantitative RT-
PCR was used to measure the expression of several miRNAs including some implicated in Zcchc11 pre-miRNA uridylation (Let-7), those highly
expressed in the livers (miR-122), and those showing trends towards change in the deep sequencing data (miR-139 and miR-379), revealing no
difference between genotypes. (C) As another approach to examining Let-7 content, Let-7a in the livers of 8-day old mice was measured by Northern
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PLOS Genetics | www.plosgenetics.org 5 November 2012 | Volume 8 | Issue 11 | e1003105about half of wild type levels (Figure 6F), suggesting that
diminished IGF-1 could contribute to systemic phenotypes. We
conclude that Zcchc11 is essential to facilitating IGF-1 expression
during neonatal periods.
Discussion
The present communication reports, to our knowledge, the first
studies of Zcchc11 in vivo. We find that Zcchc11 is widely
expressed across multiple tissues shortly after birth and that in
neonatal mice Zcchc11 deficiency results in a failure to thrive,
associated with diminished IGF-1 expression. Mice with a
complete IGF-1 deficiency have perinatal lethality and decreased
growth rates [15,16] consistent with, but more severe than, the
phenotypes observed in the Zcchc11-deficient mice. Like the
Zcchc11-deficient mice, genetic engineering that reduces but does
not eliminate IGF-1 signaling causes proportionally decreased
growth [20,21]. Zcchc11 deficiency results in decreased uridyla-
tion of miRNAs in the liver, including miRNAs that target the
IGF-1 39-UTR. Gene expression tied to this 39-UTR is enhanced
by the uridylation of miRNAs or the increased expression of
Zcchc11. Altogether, we interpret these results as supporting a
model in which the uridylation of miRNAs by Zcchc11 in the
neonatal liver is essential for optimal IGF-1 expression and its
promotion of growth and survival through the early postnatal
period. However, Zcchc11 is a large and multifunctional protein,
and we recognize that the abilities of Zcchc11 to uridylate other
substrates [19] and to exert uridylation-independent activities [18]
may additionally contribute to the complex phenotypes of
Zcchc11-deficient mice.
The decreased growth rate of Zcchc11-deficient mice is comple-
mentary to the increased growth rate observed in Lin28a-
overexpressing transgenic mice [22]. Knockdown of Lin28 and
Zcchc11 in cell lines results in similar phenotypes, and these
proteins physically interact [6,7,8]. These similarities support the
concept that Zcchc11 and Lin28 are involved in overlapping
pathways in vivo. However, the suggestion that Zcchc11-Lin28
interactions may be essential for embryonic stem cell maintenance
[6,7,8] is not supported by our observation that Zcchc11
deficiency does not impact growth or survival during embryogen-
esis. Like Zcchc11, Lin28 proteins are particularly expressed in the
tissues of young mice [23]. It will be of great interest to learn
whether mice with deficiencies in Lin28a, Lin28b or both have
phenotypes involving perinatal lethality and decreased growth, as
observed with the Zcchc11-deficient mice.
Untemplated uridines and adenines on mature miRNAs are
consistent findings in deep sequencing analyses [5,24], but the
mechanisms and significance of such terminal additions have been
difficult to discern. Previous in vitro studies had suggested that
Zcchc11 is one of several enzymes capable of end-modifying
mature miRNAs and that miRNA sequence variety might regulate
transcript expression [3,12]. The only other mouse model of PAP
mutation, mice deficient in PAPD4/GLD-2, has no reported
growth or survival phenotype [4,25]. Along with our data that
other PAPs were expressed in the neonatal livers of the Zcchc11-
deficient mice, these findings conclusively demonstrate that the
different PAPs have unique and non-overlapping roles in vivo.
Unlike GLD-2, Zcchc11 is critical for thriving through the
neonatal period, likely due in part to its ability to enhance hepatic
IGF-1 expression.
In embryonic stem cell lines, Zcchc11 knockdown increases let-
7 levels, due to Zcchc11-mediated uridylation of precursors [6,7].
The Zcchc11-deficient mice allowed the examination of miRNA
regulation in primary cells of living animals, and they revealed that
Zcchc11 is not an essential determinant of mature let-7 or any
mature miRNA quantity in the neonatal liver. Furthermore,
insertional mutagenesis of Zcchc11 did not increase let-7
quantities in primary embryonic stem cells derived from these
mice. The relationships among these terminal uridyltransferases
(Zcchc11 and Zcchc6), Lin28 proteins (a and b), and let-7
miRNAs in embryonic stem cells are complex and dynamic
[26,27]. The present data show that Zcchc11 is not an absolute
requirement for stem cell maintenance or low levels of let-7. There
may be other conditions in which precursor uridylation by
Zcchc11 is essential to regulating let-7, such as perhaps early
embryogenesis when Lin28a is especially active. This mouse model
will serve as a useful resource for determining if and when this
uridyltransferase enzyme may influence miRNA biogenesis or
content.
In contrast to the unchanged abundance of miRNAs in the
liver, mature miRNA lengths and sequences were altered by
Zcchc11 deficiency. Mature miRNAs in the liver were longer and
more likely to end in uridine, including untemplated uridines,
when Zcchc11 was present. Thus, our data show that Zcchc11
functions to uridylate mature miRNAs in vivo.
In addition to providing unprecedented evidence of an enzyme
actively uridylating the 39 terminus of miRNAs in vivo, these mice
yield new insights into the scope of Zcchc11 modification of the
miRNome. Rather than targeting only one individual miRNA, as
has been previously documented for Zcchc11 and other PAPs
[3,4,5], we show here that Zcchc11 targets the 39 terminus of
multiple miRNAs. This broad substrate repertoire dramatically
increases the potential targeting power of Zcchc11. Importantly,
most of the end-modifications observed varied by a small number
of terminal nucleotides, and we observed that even a single uridine
addition was sufficient to alleviate silencing activity. Such mono-
uridylation by Zcchc11 appears to distinguish the effect of
Zcchc11 on mature miRNAs from that described for pre-miRNAs,
which is processive and results in a string of uridines being added
[6,28]. Our data further expand our understanding of the
molecular implications of miRNA uridylation by demonstrating
that coordination of miRNA uridylation events across a 39-UTR
have combinatorial effects. The ability to adjust the silencing
activity of many miRNAs targeting one transcript provides a wide
dynamic range for enhancing gene expression. The exonuclease
Nibbler was recently identified as capable of shortening miRNAs
by removing terminal nucleotides [29,30]. Such enzymes may
counter-balance the nucleotidyltransferase activities of PAPs like
Zcchc11. The abundance and remarkable stability of miRNAs
suggest that mechanisms regulating miRNA activity are crucial,
but they are only beginning to be elucidated [31].
We propose that the miRNA 39 terminus functions as a critical
regulatory node that is remodeled by diverse enzymes to adjust
miRNA silencing and tune gene expression. The present results
support this nascent paradigm by demonstrating essential in vivo
blotting, and did not increase due to Zcchc11 deficiency. An adult wild type mouse was also included for comparison. (D) Immunoblots for RISC-
related proteins in tissue homogenates were prepared from the livers of 8 day-old mice, showing no differences due to genotype. (E) Immunoblots
for Lin-28 family members in the livers and skeletal muscles of 8 day old Zcchc11
+/+ and Zcchc11
2/2 mice revealed no effects of Zcchc11 deficiency.
Actin was measured as a loading control. For all blots, each lane represents the RNA or protein from a separate individual of the indicated age and
genotype.
doi:10.1371/journal.pgen.1003105.g002
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PLOS Genetics | www.plosgenetics.org 6 November 2012 | Volume 8 | Issue 11 | e1003105Figure 3. Zcchc11 is essential for the uridylation of miRNAs. The miRNA libraries from Zcchc11-defficent and wild type livers at 8 days of age
were analyzed for differences in sequence diversity. (A) Histogram of the number of sequences of a given read length across the libraries, showing
fewer 23 nucleotide-long reads in the mutant samples. *p,0.05 by two-way ANOVA with Bonferroni post hoc test. (B) End modifications, identified as
any nucleotide one base beyond the length of the miRNA published in miRBase, were quantified for each library. Most miRNAs ending in uridine in
the control mice did so less frequently in Zcchc11-deficient mice. The mean of the fold change in the percent of sequences adenylated or uridylated
between the knockout and wild type were graphed as waterfall plots, with every bar representing the geometric mean of (percent of miR-X
sequences modified in the mutants)/(percent of miR-X sequences modified in the WT) for the three separate libraries. Only miRNAs with .10,000
reads and .0.1% sequences end-modified in the wild type libraries were included. Data were expressed as fold-change in Zcchc11
2/2 mice
compared to Zcchc11
+/+ mice. Light grey bars indicate miRNAs with a seed sequence complementary to a portion of the IGF-1 39 UTR. (C) Average
fold change across all miRNA species shown in Figure 3B, showing that uridines but not adenines were less frequent at miRNA termini due to Zcchc11
deficiency. Error bars indicate 95% c.i. *p,0.05 vs. 0 by student’s t-test. (D) Immunoblots for the indicated non-canonical poly(A) polymerases in
tissue homogenates prepared from the livers of 8 day-old mice, showing no effect of genotype. (E) qRT-PCR for Zcchc6 expression in the livers of 8
day-old mice, showing no effect of genotype.
doi:10.1371/journal.pgen.1003105.g003
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development. Zcchc11 mediates mature miRNA uridylation,
facilitates hepatic IGF-1 expression, and enhances growth and
survival through the neonatal period.
Materials and Methods
Zcchc11-deficient mouse model
A mouse embryonic stem (ES) cell line (RRR277) containing a
gene-trap insertion in the Zcchc11 gene was obtained from
BayGenomics at the Mutant Mouse Regional Resource Center
at University of California-Davis [10]. C57BL/6 blastocysts were
microinjected with mutant ES cells to create chimeric mice that
were subsequently backcrossed onto a C57BL/6 genetic back-
ground for at least 10 generations. The gene-trap genomic
insertion site was located within intron 4 of Zcchc11, generating a
fusion protein containing the first 314 amino acids of Zcchc11
joined in frame with the b-galactosidase reporter. All known
conserved protein motifs and domains in Zcchc11 are downstream
of this site. The mutant allele was detected by genomic PCR using
the primers listed in Table S2. All murine studies were performed
under approval of the Boston University School of Medicine
IACUC.
Embryonic stem cell derivation
Eight-cell stage mouse embryos were collected in M2 medium




2/2 females mated with Zcchc11
+/+ or Zcchc11
+/2 males.
Embryos were cultured to the early blastocyst stage in KSOM
(Millipore) supplemented with 2i (1 mM PD0325901 and 3 mM
CHIR99021 (Cayman Chemical)), followed by 48 hours of culture
in Neurobasal medium supplemented with N2, B27 (Invitrogen) 2i
and Leukemia Inhibitory Factor (LIF, Millipore) at 37uC, under
5% CO2. The resulting expanded blastocysts were cultured on
laminin (Sigma, 10 mg/ml) coated tissue culture plastic in
N2B27+2i+LIF until the blastocysts had attached and outgrowths
were visible (3–4 days). These ES outgrowths were recovered by
mouth pipette, disaggregated to single cells with 0.25% Trypsin
(Invitrogen) and plated on laminin-coated tissue culture plastic to
establish embryonic stem cell lines. Cell line genotype was
determined by amplifying wild type and mutant products of
Zcchc11 alleles.
Cell line transfections
H1299 cells were plated at 2.5610
6 cells/well in 6-well plates
and transfected with 0.5 mg reporter construct, 0.25 mg phRLTK
control reporter (Promega) and 200 nM miRNA mimetic using
4 ml/well Lipofectamine 2000 (Invitrogen). EGFP or Zcchc11
constructs were transfected at 3 mg/well. Luciferase was measured
using the Dual Luciferase Reporter Assay System (Promega).
Mimetics were duplexed siRNA (Dharmacon); sequences are
presented in Table S2.
RNA and protein assays
Liver growth factors were measured by PCR Array (SA
Biosciences) using 1 mg RNA pooled from 4 Zcchc11
+/+ or 4
Zcchc11
2/2 mice. IGF-1 and 18S rRNA qRT-PCR was
performed using the TaqMan RNA-to-Ct kit (Applied Biosystems)
with primers and probes shown in Table S2. Small RNAs were
reverse transcribed using the TaqMan miRNA assay system
(Applied Biosystems). Northern blot analysis was performed on
15 mg of total RNA electrophoresed through a 1% agarose-
Figure 4. Zcchc11 stabilizes the IGF-1 39 UTR. (A) Northern blotting was used to identify the predominant IGF-1 isoform expressed in the livers
of wild type and Zcchc11-deficient mice at 8 days old. (B) The 39 UTR from this isoform, cloned onto the end of a firefly luciferase reporter and co-
transfected, along with a Renilla Luciferase containing a minimal promoter for normalization, decreased reporter expression in H1299 cells. (C) These
same constructs were transfected in H1299 cells along with plasmids encoding EGFP, Zcchc11, catalytically inactive Zcchc11 (DADA), or the N-
terminal half of Zcchc11. The full-length Zcchc11 increased expression of the IGF-1 39 UTR reporter, which was significantly inhibited by selective
mutation of the catalytic domain or complete deletion of the C terminal half. *p,0.05 vs. EGFP {p,0.05 vs Zcchc11 by one-way ANOVA.
doi:10.1371/journal.pgen.1003105.g004
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membrane. For probe creation, IGF-1 cDNA (Open Biosystems)
was digested out of a pCMV-Sport6 vector using XbaI and SalI
restriction enzymes (NEB). GAPDH probes were purchased (SA
Biosciences). Antibodies were obtained from Cell Signaling
Technologies except goat anti-Zcchc11 (ProSci), Rabbit anti-Goat
(R&D), Rabbit anti-GLD-2 (Abgent), and Rabbit anti-PAPD5
(Genetex). Whole blood was collected from the hepatic vein of 10-
week old mice or by cardiac puncture from 8-day-old litters of
Zcchc11
+/2 breeding pairs; serum was separated and components
were measured using mouse IGF-1 and GH ELISA Kits (R&D
Systems).
Cloning and plasmid construction
All Zcchc11 overexpression studies were performed using the
same plasmid backbone as the control Enhanced GFP (pEGFP-N,
Clontech). Creation of the Zcchc11 and DADA mutant plasmids
has been previously described [3]. The N-terminal region of
Figure 5. Uridylation of select miRNAs relieves silencing of the IGF-1 39 UTR. To assess miRNA targeting of IGF-1 the firefly luciferase
reporter carrying the IGF-1 39-UTR and control Renilla Luciferase (for normalization) were co-transfected into H1299 cells with various miRNA
mimetics. (A) Mimetics for miR-126-5p, miR-194-2-3p and miR-379 effectively targeted the IGF-1 39-UTR, while Let-7d did not. *p,0.05 vs. control,
N=3, by one-way ANOVA. (B) Mimetics of miR-194-2-3p, miR-126-5p, and miR-379 with or without 2 39 uridine residues were used to assess the
impact of uridylation on the effect of silencing by these miRNAs, revealing that uridylation diminished silencing by miR-126-5p and miR-379 but not
miR-194-2-3p. *p,0.05 vs. mature by two-way ANOVA by student’s t-test, N=4. (C–D) miR-126-5p or miR-379 mimetics bearing 0, 1, 2, or 4 terminal
uridines show a maximal effect on miRNA silencing by a single uridine addition. Sequences reflect those identified in sequencing libraries. *p,0.05 vs.
control by one-way ANOVA, N=4. (E) Unlike terminal uridylation, mutation of two bases in the seed sequence of miR-126-5p completely reversed
silencing of the IGF-1 39-UTR. (F) Non-uridylated or dual-uridylated mimetics of miR-126-5p and miR-379 illustrate the combinatorial role of multiple
uridylated miRNAs targeting the same transcript. *p,0.05 vs control by one-way ANOVA, N=4.
doi:10.1371/journal.pgen.1003105.g005
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Phusion High Fidelity DNA Polymerase (NEB) with the primers
indicated in Table S2. The resulting product was ligated between
NotI and BsrGI sites in the full length Zcchc11 plasmid. The full-
length IGF-1 39 UTR (Accession # NM_001111274.1) was
amplified from a cDNA library of whole liver RNA from 8 day-old
Figure 6. Zcchc11 deficiency decreases IGF-1 expression in vivo. (A) IGF-1 mRNA, measured by qRT-PCR, was decreased by Zcchc11
deficiency in 8-day-old livers. *p,0.05 vs Zcchc11
+/+ by paired student’s t-test. (B) Growth hormone (GH) in serum, measured by ELISA, was
unaffected by genotype in 8-day-old mice, based on no significant difference using student’s t-test. (C) STAT5 content and phosphorylation, as
detected by immunoblot, were unaffected by Zcchc11 deficiency in the 8-day-old liver. (D) Growth factor PCR array of the livers from 8-day-old mice
revealed IGF-1 to be the only transcript in this set to be substantially expressed and diminished by Zcchc11 deficiency. Numerical values for each
genotype indicate dCT of transcript expression normalized against the mean expression of three separate housekeeping genes. The ‘‘fold’’ column
represents the fold-change expression in Zcchc11
2/2 compared to Zcchc11
+/+ livers. (E) Histone H3 content, as detected by immunoblot, was
unaffected by Zcchc11 deficiency in the 8-day-old liver. (F) IGF-1 protein was decreased in the serum of 8-day-old Zcchc11
2/2 mice. *p,0.05 vs
Zcchc11
+/+ by student’s t-test.
doi:10.1371/journal.pgen.1003105.g006
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primers shown in Table S2. The resulting band was ligated
between SacI and MluI restriction sites into the pMir-Report
expression vector (Ambion). All plasmid constructs were se-
quenced.
Small RNA cloning and deep sequencing
Livers from 8 day-old mice were stored in RNA later (Qiagen).
Half of each liver was homogenized in BioPure RNA isolation
reagent (BiooScientific) with 0.5 mm zirconium oxide beads using
a bullet blender (Next Advance). RNA ,30 nt long was purified
from phenol-chloroform extracted RNA using a FlashPAGE
fractionator (Ambion). Small RNA library creation was performed
using an adapted Illumina small RNA sample prep v1.5.0. Briefly,
small RNA samples were adaptor ligated with one of four different
39 adaptors using T4 RNA Ligase 2 (NEB) to allow multiplex
sequencing of Zcchc11
+/+ and Zcchc11
2/2 samples. A conserved
59 adaptor was added using truncated T4 RNA Ligase 2. Samples
were gel extracted on a 10% TBE-Urea gel to remove adaptor
only ligation products. cDNA was created using SuperScript III
Reverse Transcriptase (Invitrogen) then PCR amplified with
GoTaq DNA Polymerase (Promega). Adaptor and primer
sequences are shown in Table S2. The resulting library was
sequenced on an Illumina Genome Analyzer IIx. In total, three
libraries were created each containing RNA from two Zcchc11
+/+
and two Zcchc11
2/2 sex matched littermates. Libraries were
uploaded to the NCBI Sequence Reads Archive (Accession
Number: SRA059070).
Analysis of deep sequencing data
All library analyses were performed using the Genomic
Workbench software platform (CLC Biosystems). First, sequences
were sorted by adaptor barcode and perfectly matched adaptor
sequences were trimmed while ambiguous/unrecognizable adap-
tor sequences were discarded. The samples were then grouped,
counted and aligned to v16.0 of miRBase [13,14] allowing no
more than 2 internal mismatches and no more than 5 at the 39 end
of the sequence. For identification of sequence modifications the
libraries were aligned to the mouse genome annotated with v9.0 of
the mouse database from the UCSC genome browser. SNP
detection was performed using the neighborhood quality score
algorithm [32] to identify sequence variants occurring at greater
than one per 1,000 sequences. Full genome alignment was used to
empower the use of quality scores (average quality score of 15,
minimum central quality of 20, with a window length of 5) for SNP
detection. SNP position alignment data was exported for further
analysis and adenylation/uridylation was defined as A or T
variants occurring at the position one nucleotide beyond the
published 39 terminal end of the miRNA. Unambiguous
uridylation events were defined as substitutions of a non-genomic
U for any other nucleotide at the 39 terminal end of miRNA.
Supporting Information
Figure S1 Engineering and postnatal development of
Zcchc11
2/2 mice. (A) PCR confirmation of b-gal insertion into
the Zcchc11 gene. (B) RT-PCR confirmation of b- gal
incorportation into the Zcchc11 ORF. (C) Overall body weight
of male and female wild type and Zcchc11 deficient mice through
the first 20 weeks of life. *p,0.05 by two-way ANOVA. (D) H & E





Figure S2 Significant miRNA 39 end modification in the livers
of 8-day-old mice. Levels at which (A) adenosine and (B) uridine
nucleotides were found at the 39 terminal end of miRNAs from the
livers of 8 day old control mice. The 40 most highly modified
sequences are shown. Error bars indicate standard error from
three separate libraries.
(EPS)
Table S1 Overview of library adaptor trimming and alignment.
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Table S2 Oligonucleotide sequences used in molecular analyses.
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